Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin (MyoPac)

This study has been terminated.
(Study was stopped due because recrutation.was much slower as anticipated.)
Sponsor:
Information provided by (Responsible Party):
Claudia Lorenz-Schlüter, University of Magdeburg
ClinicalTrials.gov Identifier:
NCT00691912
First received: June 4, 2008
Last updated: September 1, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)